Innovaud’s Post

Well well well, here we are again. Last week I posted about our first batch of 20 Start-ups joining us at BioTechX, now were super close to our first 30! Introducing the latest 4 Startups to join BioTechX: ADLIN Science - Created a multi-omics tool which to support labs and researchers with their Omic data analysis. This helps save time, gain scientific efficiency and valorise data. Raidium - Raidium have created an interactive AI platform which allows for access to imaging biomarkers. Allow for clinical research to be quicker which in turns helps healthcare and its patients. Xgenera - Through creating a strong diagnostic test (which works at every cancer stage), Xgenera are able to detect cancer quicker and the quicker its detected, the more treatable it is. Kaleidoscope.bio - Helping R&D teams by providing more clarity to their data which in turn helps deliver's outcomes faster and more efficiently. It also keeps key stakeholders keep up to date with the progress of any given project. If there is one word that connects all these Start-ups, its efficiency. Through making the healthcare industry even slightly more effcient can result in big positive changes and you can only bring about that level of change by working with leaders within the life science industry. Thats where BioTechX comes in, we aim to connect Start-ups with over 3000 C-level executives within the life science industry as well as investors to really showcase what these companies can do and make positive impacts within healthcare. If you are a Startup looking to network with industry leaders to help develop new partnerships in Basel this October 9-10, dont hesitate to get in touch, we still have a few spaces left! #lifescience #biotech #startups #pharma #basel

🌍 The Basel Area: Europe's Silicon Valley of Biotech Innovation The Basel Area is rapidly positioning itself as the Silicon Valley of Biotech, blending cutting-edge innovation with a thriving life sciences ecosystem. With over 700 startups, SMEs and biotech giants like #Roche and #Novartis, the region is becoming a magnet for top talent, groundbreaking research and venture capital investment. 🧬 Key Highlights: 🏢 Home to 31,000+ employees across biotech, digital health and advanced manufacturing 📈 Backed by leading investors like Novartis Venture Fund and Roche Venture Fund 🧪 Thriving research in oncology, immunology, infectious diseases and more 🏆 Supported by BaseLaunch, a premier incubator fueling biotech startups, and the leading healthtech accelerator DayOne - Healthcare Innovation With its combination of scientific excellence, political stability and strong collaboration between academia and industry, the region is set to lead the future of global biotech innovation. Read more to explore what the future holds: https://buff.ly/3VZNfHo ---- Follow us on #discoverthebaselarea Basel Area Business & Innovation #Biotech #Innovation #LifeSciences #BaselArea

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮 𝗦𝘄𝗶𝘀𝘀 𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗼𝗿 𝗮 𝗽𝗿𝗲-𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝘁𝗮𝗰𝗸𝗹𝗶𝗻𝗴 𝗽𝗿𝗼𝗯𝗹𝗲𝗺𝘀 𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝘁𝗼 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗽𝗮𝗶𝗻 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁, 𝗼𝗿 𝗔𝗜 𝗳𝗼𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁?   Then take advantage of this unique opportunity! Let Swissnex take you to Helsinki to pitch to investors and scientists at #YScience and attend Slush, one of the world’s best startup events with thousands of investors and entrepreneurs.    Applications are now open for Swiss early-stage startups and pre-startups (planning to be incorporated soon) that aim to turn science into health solutions focusing on oncology, pain treatment, or AI for health and drug development. Swissnex and the Embassy of Switzerland in Denmark have partnered with #YScience, the official side event of Slush for Life Sciences, organized by the Helsinki Institute of Life Science (HiLIFE) at the University of Helsinki in collaboration with Orion Corporation.   The finalists will receive pitching coaching, get a Startup Pass to attend Slush, pitch in the Y Science stage and in the #Swisstech Pavilion at Slush, meet potential investors, network with experts in the fields of their solution – and compete for the 5000 EUR prize for the winner!   ➡ Apply until 23 September and check more info here:  https://lnkd.in/e_J297JF

𝟭𝟱 𝗨𝗞 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵 😎 The UK is home to several biotech hubs, including the famous ‘golden triangle’, made up of Oxford, Cambridge, and London. In fact, after a $700 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe, laying the foundation for numerous companies to develop innovative technologies, some of which have spun out of the nation’s most prestigious universities. Here are 15 UK biotechs you should know: 1. Amphista Therapeutics Limited 2. Apollo Therapeutics 3. AstronauTx 4. Autolus Therapeutics  5. Bicycle Therapeutics 6. bit.bio 7. CellCentric 8. clock.bio 9. Crescendo Biologics Limited 10. EnteroBiotix 11. Evox Therapeutics Ltd 12. Exscientia  13. Jellagen 14. Sitryx 15. Quell Therapeutics In May 2023, the UK government announced a package called ‘Life Sci for Growth’, in which £650 million ($804 million) would be invested to boost the nation’s life sciences sector. The package also included plans to relaunch the Academic Health Science Network as Health Innovation Networks to boost innovation by bringing together the NHS, local communities, charities, academia, and industry to share best practices. Additionally, a week before this announcement was made, the UK Health Security Agency (UKHSA) also launched a 10-year science strategy for the nation. Both of these milestones suggest that the UK is aiming to be a global science superpower. And given the surge in biotech funding seen in the third quarter of 2023, it is no exaggeration to say that the UK’s biotech industry is currently flourishing in 2024. #biotech #startup #lifesciences #uk

✨ 𝗠𝗮𝗷𝗼𝗿 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗳𝗼𝗿 𝗡𝗫𝗜 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀: 𝗦𝗲𝗰𝘂𝗿𝗶𝗻𝗴 𝟯.𝟱 𝗠 𝗖𝗛𝗙 𝗣𝗿𝗲-𝗦𝗲𝗲𝗱 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 💰 𝑊ℎ𝑎𝑡 𝑑𝑜𝑒𝑠 𝑎 3.5 𝑀 𝐶𝐻𝐹 𝑝𝑟𝑒-𝑠𝑒𝑒𝑑 𝑓𝑢𝑛𝑑𝑖𝑛𝑔 𝑚𝑒𝑎𝑛 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑓𝑢𝑡𝑢𝑟𝑒 𝑜𝑓 𝑖𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑣𝑒 𝑖𝑚𝑚𝑢𝑛𝑜𝑡ℎ𝑒𝑟𝑎𝑝𝑖𝑒𝑠? 🥇 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 💉 NXI Therapeutics AG, a 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗼𝗳 𝗕𝗮𝘀𝗲𝗹 spin-off, is harnessing coronin 1 modulation to develop groundbreaking treatments for autoimmune diseases and transplant medicine. Their approach promises safer, more effective therapies by selectively targeting immune responses without compromising the body's defense against infections and cancer. 🏛 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆'𝘀 𝗖𝗿𝘂𝗰𝗶𝗮𝗹 𝗥𝗼𝗹𝗲 🚀 The University of Basel has been instrumental in supporting NXI Therapeutics through its Propelling grant and strategic partnerships. This collaboration underscores the university’s commitment to fostering innovation and bridging the gap between academic research and real-world applications, fulfilling at the highest level the "third mission" of a modern academic institution and the mission of the Innovation Office: 𝘱𝘳𝘰𝘱𝘦𝘭𝘭𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘰𝘳𝘴 𝘵𝘰 𝘢𝘤𝘩𝘪𝘦𝘷𝘦 𝘪𝘮𝘱𝘢𝘤𝘵! 🌟 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗶𝗻 𝗮 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗶𝗻𝗴 𝗖𝗹𝗶𝗺𝗮𝘁𝗲 ⛈ In a difficult period for startup fundraising, securing 3.5 million CHF from prominent investors like 𝗝𝗙𝗚 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻, 𝗕𝗮𝘀𝗲𝗟𝗮𝘂𝗻𝗰𝗵, 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗞𝗶𝗰𝗸, and 𝗞𝗶𝗰𝗸𝗳𝘂𝗻𝗱 is a remarkable achievement. It highlights the critical need for continued support and investment in early-stage ventures to drive transformative healthcare solutions. At the Innovation Office of the University of Basel, we are proud to celebrate this significant achievement, which exemplifies our commitment to nurturing groundbreaking innovations and supporting startups in their journey from academia to impactful real-world applications. Looking forward for even bigger successes to come - 𝗵𝘂𝗴𝗲 𝗰𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗡𝗫𝗜 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘁𝗲𝗮𝗺! We will share more insights about this incredible startup venture very soon - so follow-us and stay tuned! You can find a few info and the official press release below. #InnovationEcosystem #LifeSciences #Biotech #StartupFunding #UniversityOfBasel #Immunotherapy #HealthcareInnovation

For foreign companies looking to grow, expand, or optimize costs, the Basel Area offers exceptional opportunities. Whether you're considering relocation, setting up a new HQ, or establishing a branch, this region is the ideal place to thrive. With its cutting-edge biotech ecosystem, access to top talent, and strong support from industry leaders like Roche and Novartis, Basel is at the forefront of innovation. Looking for a smooth transition? Ceppi Consulting provides an all-inclusive, turnkey service to ensure your office is ready for business – hassle-free and fully compliant. Contact us to learn more about how we can support your company's expansion. #Biotech #LifeSciences #Innovation #BusinessExpansion #BaselArea #Roche #Novartis #CeppiConsulting #Startups #HQRelocation #CorporateGrowth #VentureCapital #BusinessConsulting #SwissBusiness #TurnkeySolutions

Accelerating Impactful Research Ideas To Market In today's fast-paced biomedical landscape, identifying promising assets, potential partners, and emerging technologies is crucial for companies looking to stay competitive and innovative. OniX Hub offers a groundbreaking solution to this challenge with its comprehensive Biotech and Startups Assets & Pipeline Dataset. This white paper explores how OniX Hub empowers companies to rapidly discover and evaluate early-stage assets, researchers, and potential collaborators, ultimately accelerating their R&D pathways. https://lnkd.in/d_bPbcD

CHF 14 Million to advance life-saving blood purification technology: TOP 100 Swiss startup hemotune AG raises Series B2 funding. Congrats and best of success onwards to Lukas Langenegger and his team of medtech innovators! https://lnkd.in/dWQ9kGxf The investment was led by Belmondo and existing investors including VP Venture Partners, HEMEX, OCCIDENT, Zürcher Kantonalbank, and joined by EFI. About: hemotune AG is developing a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct removal of disease-causing substances from the blood stream of a patient. The technology targets a broad range of harmful compounds such as toxins, pathogenic organisms, or overdosed drugs. Moreover, by being more targeted, efficient, and gentler than previous blood filters, we outperform state of the art therapies and improve patient outcomes. Hemotune is a 2017 alumnus of Venture Kick and three-time laureate of the TOP 100 Swiss Startup Award. #VentureKick #SwissStartups #TOP100SSU

🌟 Why Attending the TRANSFORMATION SERIES#2 Event in Lyon is Essential for Lifescience Innovators? 🌟 Excited to share that I’ll be attending the upcoming Innocircle event in Lyon! This event is not just a gathering; it’s a vital platform for anyone in the lifescience sector looking to innovate and thrive in our rapidly changing environment. As we explore the themes of innovation, funding, and growth, one fundamental pillar stands out: 🗣️ the power of narrative ! In today’s complex landscape, a compelling narrative is essential for: 🧲 Engaging Stakeholders: Whether it's investors, partners, or the community, a clear and impactful story helps convey the value of our innovations. 💱 Driving Change: In a field that evolves at lightning speed, narratives allow us to connect our innovations to real-world needs, making our projects more relatable and urgent. 🤝 Building Trust: Transparency and authenticity in our storytelling foster trust among collaborators and customers, which is crucial for long-term success. I look forward to connecting with thought leaders, Kasia Hein-Peters, MD, Oréda BOUSSADIA, PhD, MBA, Philippe Méresse, Catherine Sirven and Djomangan Adama OUATTARA to delve deeper into how we can harness the power of narrative to enhance our projects and drive positive change in the lifescience industry. Join us in Lyon in Bayer Crop Science | Innovation Ecosystem #LifeHubLyon to share insights, foster connections, and strengthen our collective impact. Let’s innovate, fund, and thrive together! Register here: https://lnkd.in/e98AdcR9 Interested in our book co-written with Jean-François Denault and published by Taylor & Francis Group ? 👉 https://lnkd.in/eksmdXG4 #Innocircle #Lifescience #Innovation #Narrative #Funding #Networking #transformation #innovationculture #agilemarketing #digitalization #fundraising #pharma #biotech #medtech #startup #lyon #event

We are proud to announce the launch of our new biotech startup InVirtuoLabs after months of stealth work. InVirtuoLabs is a new-generation laboratory for drug discovery based in #Switzerland, aiming to disrupt the way we currently design drugs. InVirtuoLabs combines advanced machine learning techniques—including multimodal learning, active learning and generative chemistry—with physics-based simulations to rapidly identify and optimize promising drug candidates. And our achievements so far? A committed founding team of scientists, pharma experts, and business transformers already on board; the speedy acceptance into the Ticino-based accelerator Boldbrain Startup Challenge ; the launch of a pre-seed fundraising campaign already on its way to a 7-digit funding commitment; and a pipeline of proprietary drug discovery projects. Are you a pharma or non-pharma entity striving to boost your drug discovery power? Are you a private or institutional investor looking for a solid biotech project to support? Are you a scientist looking for partners to identify molecules for your targets? Please contact us. InVirtuoLabs commits to accelerating the path from concept to life-changing therapies. Check out our site at https://lnkd.in/d7DDdeUB #biotech #pharmatech #medtech #nextgenerationlab #drugdiscovery #AI Gianvito Grasso Sertac Yeltekin Stefano Muscat Francesco Gentile Diego Piovan Claudio Pietra Giacomo Di Benedetto Maria Veronika Stattin Alessandro Grande Jack Tuszynski Demet Olesen Gabriele Maroni